Evidence map›Paper›PMID 36500650›Full record

ArticleMolecules (Basel, Switzerland)2022

Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?

Gabriela Corrêa Carvalho, Gabriel Davi Marena, Gabriela Ricci Leonardi, Rafael Miguel Sábio, Ione Corrêa, Marlus Chorilli, Tais Maria Bauab

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Nanomaterials (Basel, Switzerland) · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gabriela Corrêa CarvalhoSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.ORCID 0000-0002-4071-5364
Gabriel Davi MarenaSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.ORCID 0000-0002-4573-5743
Gabriela Ricci LeonardiFaculty of Medicine, University of Ribeirão Preto (UNAERP), Ribeirão Preto 14096-900, Brazil.
Rafael Miguel SábioSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.ORCID 0000-0002-3852-2184
Ione CorrêaMedical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.ORCID 0000-0002-8953-9058
Marlus ChorilliSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.ORCID 0000-0002-6698-0545
Tais Maria BauabSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.
Universidade Estadual Paulista (Unesp) · BRUniversidade de Ribeirão Preto · BR

Funding

São Paulo Research Foundation 2018/25377-3São Paulo Research Foundation 2019/09831-9São Paulo Research Foundation 2019/26821-7
6 · The paper itself

Abstract

Commonly found colonizing the human microbiota,

Indexed as

Candidiasis, VulvovaginalFluconazoleAgedAntifungal AgentsCandidaCandida albicansFemaleHumansLycopeneMicrobial Sensitivity TestsPregnancySilicon DioxideAntifungal AgentsFluconazoleLycopeneSilicon Dioxideantifungal activitycarotenoidGalleria mellonellalycopenemesoporous silica nanoparticlesnatural products

Identifiers

PMID36500650
PMCPMC9738730
OpenAlexW4311628032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.